Inventor · disambiguated record
Martin C. Woodle
Also filed as: WOODLE MARTIN · WOODLE MARTIN C
20 granted patents·19 pending applications·6,250 citations·filing 1989–2011
97Inventor score
Top patents by PatentIndex Score
39 records- 0198US5395619ALipid-polymer conjugates and liposomesLIPOSOME TECHNOLOGY INC·Filed 1993·Granted Mar 7, 1995·566 cites·6 claims
- 0298US5356633AMethod of treatment of inflamed tissuesLIPOSOME TECHNOLOGY INC·Filed 1992·Granted Oct 18, 1994·532 cites·6 claims
- 0398US5225212AMicroreservoir liposome composition and methodLIPOSOME TECHNOLOGY INC·Filed 1990·Granted Jul 6, 1993·754 cites·26 claims
- 0498US5213804ASolid tumor treatment method and compositionLIPOSOME TECHNOLOGY INC·Filed 1991·Granted May 25, 1993·682 cites·15 claims
- 0598US5013556ALiposomes with enhanced circulation timeLIPOSOME TECHNOLOGY INC·Filed 1989·Granted May 7, 1991·2.9k cites·33 claims
- 0697US5631018ALipid-polymer conjugates and liposomesSEQUUS PHARM INC·Filed 1994·Granted May 20, 1997·349 cites·12 claims
- 0795US6180134B1Enhanced ciruclation effector composition and methodSEQUUS PHARM INC·Filed 1995·Granted Jan 30, 2001·130 cites·7 claims
- 0893US5843473AMethod of treatment of infected tissuesSEQUUS PHARM INC·Filed 1992·Granted Dec 1, 1998·111 cites·5 claims
- 0992US7534878B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2007·Granted May 19, 2009·22 cites·32 claims
- 1092US4927637ALiposome extrusion methodLIPOSOME TECHNOLOGY INC·Filed 1989·Granted May 22, 1990·145 cites·7 claims
- 1189US7893244B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2008·Granted Feb 22, 2011·7 cites·29 claims
- 1289US7723316B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2007·Granted May 25, 2010·12 cites·47 claims
- 1388US7786092B2Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2009·Granted Aug 31, 2010·11 cites·27 claims
- 1485US7160554B2Enhanced circulation effector composition and methodALZA CORP·Filed 2003·Granted Jan 9, 2007·11 cites·48 claims
- 1585US6586002B2Enhanced circulation effector composition and methodALZA CORP·Filed 2001·Granted Jul 1, 2003·11 cites·48 claims
- 1684US7893243B2Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2007·Granted Feb 22, 2011·6 cites·35 claims
- 1776US8691781B2Compositions for treating respiratory viral infections and their useTANG QINGQUAN·Filed 2005·Granted Apr 8, 2014·4 cites·21 claims
- 1874US7150882B2Enhanced circulation effector composition and methodALZA CORP·Filed 2004·Granted Dec 19, 2006·2 cites·48 claims
- 1971US2007087047A1Enhanced circulation effector composition and methodALZA CORP·Filed 2006·Application pending·0 cites
- 2070US7781414B2Targets for tumor growth inhibitionINTRADIGM CORP·Filed 2004·Granted Aug 24, 2010·2 cites·31 claims
- 2167US6326353B1Enhanced circulation effector composition and methodSEQUUS PHARM INC·Filed 1993·Granted Dec 4, 2001·19 cites·4 claims
- 2261US2008153771A1Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesLIU YIJIA·Filed 2007·Application pending·0 cites
- 2359US2010203036A1Targets for tumor growth inhibitionINTRADIGM CORP·Filed 2009·Application pending·0 cites
- 2452US2011124710A1Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseasesINTRADIGM CORP·Filed 2011·Application pending·0 cites
- 2551US2011312877A1Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic useBERNINGER MARK·Filed 2009·Application pending·0 cites
- 2650US2003113369A1Liposomes with enhanced circulation time and method of treatmentFiled 2002·Application pending·0 cites
- 2748US2007237718A1Multi-disciplinary approach to validating or indentifying targets using an in vivo systemLU PATRICK Y·Filed 2007·Application pending·0 cites
- 2847US2007219118A1Therapeutic methods for nucleic acid delivery vehiclesINTRADIGM CORP·Filed 2006·Application pending·0 cites
- 2947US2001051183A1Liposomes with enhanced circulation time and method of treatmentALZA CORP·Filed 2001·Application pending·0 cites
- 3046US2011038849A1Inhibitory polynucleotide compositions and methods for treating cancerINTRADIGM CORP·Filed 2006·Application pending·0 cites
- 3142US2004067543A1Multi-disciplinary approach to validating or identifying targets using an in vivo systemFiled 2003·Application pending·0 cites
- 3242US2007203082A1RNAI Agents For Anti-SARS Coronavirus TherapyINTRADIGM CORP·Filed 2004·Application pending·0 cites
- 3342US2010028848A1Compositions and Methods of Using siRNA to Knockdown Gene Expression and to Improve Solid Organ and Cell TransplantationINTRADIGM CORP·Filed 2006·Application pending·0 cites
- 3441US2003138407A1Therapeutic methods for nucleic acid delivery vehiclesFiled 2002·Application pending·0 cites
- 3541US2006211637A1Methods of down regulating target gene expression in vivo by introduction of interfering rnaINTRADIGM CORP·Filed 2003·Application pending·0 cites
- 3638US2009247604A1RNAi Therapeutics for Treatment of Eye Neovascularization DiseasesINTRADIGM CORP·Filed 2005·Application pending·0 cites
- 3737US2006014695A1Hpma-polyamine conjugates and uses thereforeGHANDEHARI HAMIDREZA·Filed 2003·Application pending·0 cites
- 3833US2003166601A1Novel colloid synthetic vectors for gene therapyFiled 2002·Application pending·0 cites
- 3929US2006051315A1Polymers for delivering peptides and small molecules in vivoSCARIA PUTHUPPARAMPIL V·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →